Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia.
Montanaro A, Kitara S, Cerretani E, Marchesini M, Rompietti C, Pagliaro L, Gherli A, Su A, Minchillo ML, Caputi M, Fioretzaki R, Lorusso B, Ross L, Alexe G, Masselli E, Marozzi M, Rizzi FMA, La Starza R, Mecucci C, Xiong Y, Jin J, Falco A, Knoechel B, Aversa F, Candini O, Quaini F, Sportoletti P, Stegmaier K, Roti G. Montanaro A, et al. Among authors: rompietti c. Cell Death Dis. 2022 Jun 17;13(6):551. doi: 10.1038/s41419-022-05002-5. Cell Death Dis. 2022. PMID: 35710782 Free PMC article.
Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
Baldoni S, Del Papa B, Dorillo E, Aureli P, De Falco F, Rompietti C, Sorcini D, Varasano E, Cecchini D, Zei T, Di Tommaso A, Rosati E, Alexe G, Roti G, Stegmaier K, Di Ianni M, Falzetti F, Sportoletti P. Baldoni S, et al. Among authors: rompietti c. Int J Cancer. 2018 Aug 15;143(4):958-970. doi: 10.1002/ijc.31355. Epub 2018 Mar 23. Int J Cancer. 2018. PMID: 29508386 Free PMC article.
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia.
Marchesini M, Gherli A, Montanaro A, Patrizi L, Sorrentino C, Pagliaro L, Rompietti C, Kitara S, Heit S, Olesen CE, Møller JV, Savi M, Bocchi L, Vilella R, Rizzi F, Baglione M, Rastelli G, Loiacono C, La Starza R, Mecucci C, Stegmaier K, Aversa F, Stilli D, Lund Winther AM, Sportoletti P, Bublitz M, Dalby-Brown W, Roti G. Marchesini M, et al. Among authors: rompietti c. Cell Chem Biol. 2020 Jun 18;27(6):678-697.e13. doi: 10.1016/j.chembiol.2020.04.002. Epub 2020 May 7. Cell Chem Biol. 2020. PMID: 32386594 Free PMC article.
GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL.
De Falco F, Rompietti C, Sorcini D, Esposito A, Scialdone A, Baldoni S, Del Papa B, Adamo FM, Silva Barcelos EC, Dorillo E, Stella A, Di Ianni M, Screpanti I, Sportoletti P, Rosati E. De Falco F, et al. Among authors: rompietti c. Cell Death Dis. 2022 Sep 1;13(9):755. doi: 10.1038/s41419-022-05178-w. Cell Death Dis. 2022. PMID: 36050315 Free PMC article.
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.
Rosati E, Baldoni S, De Falco F, Del Papa B, Dorillo E, Rompietti C, Albi E, Falzetti F, Di Ianni M, Sportoletti P. Rosati E, et al. Among authors: rompietti c. Front Oncol. 2018 Jun 27;8:229. doi: 10.3389/fonc.2018.00229. eCollection 2018. Front Oncol. 2018. PMID: 29998084 Free PMC article. Review.
NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.
Sportoletti P, De Falco F, Del Papa B, Baldoni S, Guarente V, Marra A, Dorillo E, Rompietti C, Adamo FM, Ruggeri L, Di Ianni M, Rosati E. Sportoletti P, et al. Among authors: rompietti c. Int J Mol Sci. 2021 Jun 22;22(13):6665. doi: 10.3390/ijms22136665. Int J Mol Sci. 2021. PMID: 34206399 Free PMC article. Review.
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia.
Guarente V, Martino G, Dorillo E, De Falco F, Rompietti C, Sorcini D, Brogna M, Cardinali V, Ascani S, Marra A, Sportoletti P. Guarente V, et al. Among authors: rompietti c. Front Oncol. 2021 Sep 9;11:729106. doi: 10.3389/fonc.2021.729106. eCollection 2021. Front Oncol. 2021. PMID: 34568060 Free PMC article.
Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia.
Adamo FM, Silva Barcelos EC, De Falco F, Dorillo E, Rompietti C, Sorcini D, Stella A, Del Papa B, Baldoni S, Esposito A, Geraci C, Arcaleni R, Pennetta C, Ragonese F, Moretti L, Mameli M, Di Ianni M, Rosati E, Fioretti B, Sportoletti P. Adamo FM, et al. Among authors: rompietti c. Cancers (Basel). 2023 Jul 14;15(14):3618. doi: 10.3390/cancers15143618. Cancers (Basel). 2023. PMID: 37509279 Free PMC article.
NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential.
Silva Barcelos EC, Rompietti C, Adamo FM, Dorillo E, De Falco F, Del Papa B, Baldoni S, Nogarotto M, Esposito A, Capoccia S, Geraci C, Sorcini D, Stella A, Arcaleni R, Tini V, Imbroisi Valle Errera F, Rosati E, Sportoletti P. Silva Barcelos EC, et al. Among authors: rompietti c. Front Oncol. 2023 Sep 25;13:1218989. doi: 10.3389/fonc.2023.1218989. eCollection 2023. Front Oncol. 2023. PMID: 37817771 Free PMC article.
FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia.
Sorcini D, Stella A, Scialdone A, Sartori S, Marra A, Rossi R, De Falco F, Adamo FM, Dorillo E, Geraci C, Arcaleni R, Rompietti C, Esposito A, Moretti L, Mameli MG, Martelli MP, Falini B, Sportoletti P. Sorcini D, et al. Among authors: rompietti c. EJHaem. 2023 Sep 11;4(4):1100-1104. doi: 10.1002/jha2.738. eCollection 2023 Nov. EJHaem. 2023. PMID: 38024637 Free PMC article.
16 results